We are live on ! Find out more
APTX

Aptinyx Inc. Common Stock

Delisted

APTX was delisted on the 18th of May, 2023.

53 hedge funds and large institutions have $57.3M invested in Aptinyx Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 24 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

8% more funds holding

Funds holding: 4953 (+4)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

6% less capital invested

Capital invested by funds: $60.8M → $57.3M (-$3.52M)

79% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 24

Holders
53
Holders Change
+4
Holders Change %
+8.16%
% of All Funds
1.04%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
11
Increased
5
Reduced
24
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
ASP
1
Adams Street Partners
Illinois
$14.1M
NLVP
2
New Leaf Venture Partners
New York
$11.3M
FM
3
Frazier Management
Washington
$10.9M
BCLSI
4
Bain Capital Life Sciences Investors
Massachusetts
$7.61M
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.03M
FCM
6
Farallon Capital Management
California
$1.4M -$915K -265,592 -39%
BlackRock
7
BlackRock
New York
$1.27M -$1.07M -311,127 -46%
Renaissance Technologies
8
Renaissance Technologies
New York
$1.05M +$756K +219,450 +249%
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$639K +$352K +102,332 +121%
OAM
10
Oxford Asset Management
United Kingdom
$594K -$178K -51,797 -23%
JP Morgan Chase
11
JP Morgan Chase
New York
$539K -$162K -47,113 -23%
BCM
12
Bridgeway Capital Management
Texas
$500K +$204K +59,300 +68%
Marshall Wace
13
Marshall Wace
United Kingdom
$493K -$245K -71,195 -33%
O
14
OrbiMed
New York
$489K +$492K +143,000 New
Two Sigma Investments
15
Two Sigma Investments
New York
$412K -$159K -46,194 -28%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$385K +$16.7K +4,838 +4%
NU
17
Northwestern University
Illinois
$374K
MA
18
MYDA Advisors
New York
$329K +$331K +96,059 New
DA
19
DCF Advisers
Connecticut
$312K +$314K +91,300 New
Two Sigma Advisers
20
Two Sigma Advisers
New York
$282K -$34.4K -10,000 -11%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$267K -$4.29K -1,245 -2%
Morgan Stanley
22
Morgan Stanley
New York
$250K -$1.33M -387,274 -84%
Millennium Management
23
Millennium Management
New York
$249K -$120K -34,930 -32%
Goldman Sachs
24
Goldman Sachs
New York
$209K -$12.9K -3,744 -6%
HSBC Holdings
25
HSBC Holdings
United Kingdom
$162K -$165K -47,777 -50%

APTX Hedge Fund Activity: Q4 2019 in Review

53 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q4 2019, worth a combined $57.3M — down 5.8% from $60.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new APTX positions and 7 closed out — a net gain of 4 holders — while 5 added to existing stakes and 24 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $756K. The largest seller was Morgan Stanley, cutting an estimated $1.33M.

  • 53 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q4 2019, up from 49 in Q3 2019.
  • Funds reported $57.3M of Aptinyx Inc. Common Stock stock for Q4 2019, down 5.8% quarter-over-quarter.
  • 11 funds opened new Aptinyx Inc. Common Stock positions in Q4 2019 and 7 closed out, a net change of +4 holders.
  • The largest Aptinyx Inc. Common Stock buyer in Q4 2019 was Renaissance Technologies, an estimated $756K added.
  • The largest Aptinyx Inc. Common Stock seller in Q4 2019 was Morgan Stanley, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2019.